I went digging into a routine bond announcement from UOB this week and ended up somewhere far more interesting. While checking an unconfirmed price move, I pulled three live fair value estimates for the same stock, same day, same public data, and they didn’t just differ slightly, one said discount and another said overpriced. If you’ve ever read a “this stock is undervalued” headline and taken it at face value, this episode shows you exactly why that instinct needs a second look before it touches your CPF or SRS money.
Key takeaways:
UOB raised S$500 million euros via a covered bond maturing 2031, a routine funding move, not a distress signal.
Share price sat near S$42.20 today but flagged as delayed data, with no confirmed link to the bond news.
Crowd-sourced model: S$43.40 fair value, roughly a 5% discount.
Analyst consensus: S$42.98, rating split mostly Hold.
Same provider’s internal model: S$36.37, implying the stock is already overvalued.
Iggy’s Forensic Disclaimer
This content is produced for educational and informational purposes only. I am not a financial advisor — I am a retail investor who applies forensic analysis to my own portfolio and shares that process publicly. Nothing here constitutes a recommendation to buy, sell, or hold any security, and no specific target prices or personalised financial advice are offered. Stocks assessed under Iggy’s Forensic Yield Standard are benchmarked against a 4.7% minimum yield hurdle; stocks flagged as Growth Watch fall below this threshold but demonstrate clean balance sheet metrics and an identifiable growth catalyst — these carry a materially different risk profile and are not suitable as yield replacements for income-dependent investors. All data is sourced from public filings and verified sources; where data is unverified it is explicitly flagged. All investments carry risk, including the potential loss of principal, and past performance is not indicative of future results. If you are making investment decisions involving CPF, SRS, or personal capital, please conduct your own due diligence or consult a MAS-licensed financial adviser before committing funds.
